We use Google Analytics to count anonymous page views and understand which content gets read. No ads, no profiles. Decline keeps you on cookieless mode. Details.
Centene Corporation
Health Care · Managed Health Care
1M). Earnings = premiums minus medical costs; MLR is the entire P&L lever. State rebid cycles (TX, CA, NY, FL renewals 2026-2027) determine multi-year revenue base. Redeterminations unwind (post-2026 cliff) compressed Medicaid margins; ACA enhanced subsidies expire end-2026 absent Congressional extension.
ACA marketplace 50%+ enrollment growth 2024-2025; Medicare Advantage Stars recovery underway (HEDIS investments paying off in 2027 bonus year); Medicaid acuity normalizing as post-COVID redeterminations complete; share buybacks at ~6-7x fwd P/E with $2B+ annual FCF; divested non-core (Magellan Rx, Circle Health, Apixio) cleans up the story; SG&A ratio compressing toward 8% target.
ACA subsidy cliff end-2026 = potential 30-40% Ambetter enrollment hit if not extended; Medicare Advantage Stars cut hits 2026 bonus payments (already guided down); Medicaid MLR running hot (~89-90%) as redeterminations leave higher-acuity book; state rate inadequacy in CA + NY pressures 2026 margins; binary political risk (Medicaid block grants, ACA repeal narrative).
Each weekday: the scan's ENTER setups with entry, stop and target, every new ticker teardown, and the bubble shifts that move names like this one. Free. Education, not advice.
No spam. One email per day max. Pro adds Telegram trade alerts and higher AI-assistant limits.
No major news in the last 7 days for CNC - only listicles and opinion pieces, which we filter out by default. See everything anyway.
Auto-computed retracement of the trailing 52w low-high leg. Recomputed on each refresh; not a curated level.
Auto-computed retracement of the trailing 52w low-high leg. Recomputed on each refresh; not a curated level.